Overview and Scope
Catalepsy treatment refers to a procedure that focuses on reducing the symptoms of catalepsy such as loss of voluntary motion, fixed posture, and decreased sensitivity to pain by using medication and muscle relaxants. They are used for reducing muscle rigidity.
Sizing and Forecast
The catalepsy treatment market size has grown strongly in recent years. It will grow from $80.96 billion in 2023 to $86.51 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to economic factors, awareness and education, healthcare infrastructure development, drug approvals and regulatory landscape, advancements in medical research.
The catalepsy treatment market size is expected to see strong growth in the next few years. It will grow to $113.46 billion in 2028 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to investment and funding, global health trends, patient advocacy and awareness programs, healthcare policy changes, innovations in drug development. Major trends in the forecast period include collaborative research initiatives, neurostimulation therapies, regulatory landscape changes, patient advocacy and awareness, digital health integration.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/catalepsy-treatment-global-market-report
Segmentation & Regional Insights
The catalepsy treatment market covered in this report is segmented –
1) By Type: Drugs, Psychotherapy, Other Types
2) By Route of Administration: Oral, Parenteral, Other Routes
3) By End User: Hospitals, Specialty Clinics, Other Users
North America was the largest region in the catalepsy treatment market in 2023. The regions covered in the catalepsy treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9431&type=smp
Major Driver Impacting Market Growth
The growing prevalence of chronic diseases is expected to propel the catalepsy treatment market going forward. Chronic conditions are illnesses or conditions that typically endure for three months or longer and may deteriorate over time. The majority of chronic diseases can be managed but not cured, and they typically affect older persons. The prevalence of catalepsy is rising along with other toxic or infectious diseases linked to chronic illnesses, requiring catalepsy treatment. For instance, in September 2022, according to the World Health Organization, a US-based specialized agency responsible for international public health, about 41 million people will die each year, which is equivalent to 74% of all deaths globally, because of chronic noncommunicable diseases (NCD). Further, all the NCD deaths will be around 77% in low- and middle-income countries. Therefore, the growing prevalence of chronic diseases is driving the catalepsy treatment market.
Key Industry Players
Major companies operating in the catalepsy treatment market are focusing on innovative products such as baclofen oral granules to drive revenues in their market. Baclofen oral granules refer to a form of the medication baclofen that comes in granular or powder form, designed to be taken orally. For instance, in June 2022, Amneal Pharmaceuticals, Inc. a US-based pharmaceutical company launched lyvispah. Lyvispah works on spinal cord nerves to lessen the frequency and intensity of muscular spasms in people with specific spinal cord-related disorders. This is a strawberry-flavored, dissolvable granular formulation of baclofen that comes in packets containing 5 mg, 10 mg, and 20 mg. It can be purchased through specialist and retail channels.
The catalepsy treatment market report table of contents includes:
1. Executive Summary
- Market Characteristics
- Market Trends And Strategies
- Impact Of COVID-19
- Market Size And Growth
- Segmentation
- Regional And Country Analysis
………
- Competitive Landscape And Company Profiles
- Key Mergers And Acquisitions
- Future Outlook and Potential Analysis
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
